Your browser doesn't support javascript.
loading
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Hosokawa, Shinobu; Ichihara, Eiki; Harada, Daijiro; Kuyama, Shoichi; Inoue, Koji; Gemba, Kenichi; Ichikawa, Hirohisa; Kato, Yuka; Oda, Naohiro; Oze, Isao; Tamura, Tomoki; Kozuki, Toshiyuki; Umeno, Takahiro; Kubo, Toshio; Hotta, Katsuyuki; Bessho, Akihiro; Maeda, Yoshinobu; Kiura, Katsuyuki.
Afiliação
  • Hosokawa S; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Ichihara E; Department of Allergy and Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho Kita-ku, Okayama City, Okayama, 700-8558, Japan. ichiha-e@md.okayama-u.ac.jp.
  • Harada D; Department of Thoracic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.
  • Kuyama S; Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan.
  • Inoue K; Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Gemba K; Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan.
  • Ichikawa H; Department of Respiratory Medicine, KKR Takamatsu Hospital, Takamatsu, Japan.
  • Kato Y; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Oda N; Department of Respiratory Medicine, Fukuyama City Hospital, Fukuyama, Japan.
  • Oze I; Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Tamura T; Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan.
  • Kozuki T; Department of Thoracic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.
  • Umeno T; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Kubo T; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
  • Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Bessho A; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Maeda Y; Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho Kita-ku, Okayama City, Okayama, 700-8558, Japan.
Int J Clin Oncol ; 27(7): 1139-1144, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35534642
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article